Insights
  • Oura
  • Garmin

3.42% of Oura Ring Buyers Purchased an OTC Glucose Monitor, vs. 1.63% of Garmin Buyers

In our U.S. e-receipt panel, 181 of 5,293 Oura Ring buyers purchased Stelo or Lingo from Jan. 2024–Aug. 2026, vs. 1.63% of Garmin and 1.50% of Peloton buyers.

Oura Ring buyers purchased OTC glucose monitors at more than twice the Garmin- and Peloton-buyer rates

Share of established wearable buyers with a Dexcom Stelo or Abbott Lingo receipt, January 2024–August 2026

Source: YipitData U.S. e-receipt panel. Oura Ring n=5,293 with 181 glucose-monitor buyers; Garmin n=7,652 with 125; Peloton n=9,342 with 140; active panel n=1,207,958 with 2,029. Moderate numerators make second-decimal rates directional.

Chart data

Oura Ring buyers purchased OTC glucose monitors at more than twice the Garmin- and Peloton-buyer rates
SeriesShare purchasing an OTC glucose monitor
Oura Ring buyers3.42%
Garmin buyers1.63%
Peloton buyers1.5%
Active panelists0.17%

Which OTC glucose monitors did Oura Ring buyers purchase?

In a separate, broader cohort of 275 Oura Ring buyers with an observed glucose-monitor purchase, 70% bought Dexcom Stelo and 40% bought Abbott Lingo; 30% bought only Lingo. Some buyers purchased both devices, so the Stelo and Lingo shares overlap. This broader cohort begins with 2023 ring buyers and does not share the adoption chart’s denominator.

When did Oura Ring buyers adopt an OTC glucose monitor?

In the broader 275-person device-mix cohort, 62%, or 170 buyers, first showed an OTC glucose-monitor purchase in May 2025 or later. OTC devices launched only in mid-2024, so this timing is descriptive and cannot establish that Oura ownership or any product integration caused adoption.

Assumptions & Methodologies

We analyzed established U.S. e-receipt panelists from Jan. 2024–Aug. 2026. Wearable cohorts required a hardware receipt: Oura Ring of at least $250 (n=5,293), Garmin n=7,652, and Peloton n=9,342; the active panel had 1.2 million people. OTC glucose monitoring meant a Dexcom Stelo or Abbott Lingo receipt. A separate broader cohort of 275 Oura Ring buyers with an all-time glucose-monitor receipt measured device mix and timing. That cohort does not share the chart denominator. Second-decimal rates are directional because numerators are moderate. Hardware-price proxies can misclassify, subscription-only wearables are not reliably captured, and associations do not show Oura caused adoption.

Keep exploring

Ask a follow-up question

Take this research one step further with YipitData.

Did OTC glucose-monitor adoption vary by Oura Ring generation or buyer tenure?

How often did Oura Ring buyers purchase both Stelo and Lingo over time?

Did Oura membership retention differ among buyers with and without a glucose-monitor purchase?

Data sources

Email Receipt PanelDigital purchases and subscription behavior